- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CUPRINA HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 16.06. | Cuprina Holdings Falls 22% After 112% Rally - Here's Why CUPR Stock Is Trending | 3 | Benzinga.com | ||
| 15.06. | Cuprina erhält FDA-Zulassung für Produkt zur Madentherapie | 6 | Investing.com Deutsch | ||
| 15.06. | Cuprina receives FDA clearance for maggot wound therapy product | 1 | Investing.com | ||
| 15.06. | Cuprina Holdings (Cayman) LTD: Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots - the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product | 216 | GlobeNewswire (Europe) | SINGAPORE, June 15, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("CUPR" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 12.06. | Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements | 346 | GlobeNewswire (Europe) | SINGAPORE, June 12, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 12.06. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.05. | Cuprina requests Nasdaq hearing after delisting notice | 2 | Investing.com | ||
| 29.05. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing | 157 | GlobeNewswire (Europe) | SINGAPORE, May 29, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings Cayman Limited Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 22.05. | Cuprina to implement 1-for-8 share consolidation to address Nasdaq compliance | 1 | Seeking Alpha | ||
| 22.05. | Cuprina plant Aktienzusammenlegung im Verhältnis 1:8 zur Sicherung der NASDAQ-Notierung | 5 | Investing.com Deutsch | ||
| 22.05. | Cuprina plans 1-for-8 reverse stock split to meet Nasdaq rules | 1 | Investing.com | ||
| 22.05. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings announces 1-for-8 Share Consolidation | 357 | GlobeNewswire (Europe) | SINGAPORE, May 22, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 14.05. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.04. | Cuprina Holdings LTD - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 21.04. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 11.03. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board | 740 | GlobeNewswire (Europe) | SINGAPORE, March 11, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic... ► Artikel lesen | |
| 11.03. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 09.12.25 | Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth | 355 | GlobeNewswire (Europe) | SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 28.11.25 | Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency | 379 | GlobeNewswire (Europe) | SINGAPORE, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 30.06.25 | Cuprina Holdings (Cayman) LTD: Cuprina Provides Update on Research Studies with Three Leading Education Institutes | 530 | GlobeNewswire (Europe) | SINGAPORE, June 30, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical and biotechnology company dedicated to the development and... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CO-DIAGNOSTICS | 3,290 | +5,45 % | Co-Diagnostics hosts Saudi joint venture for manufacturing tour | ||
| CYTOSORBENTS | 0,386 | +5,46 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | PRINCETON, N.J., May 13, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 4,490 | 0,00 % | Jim Cramer Says Clover Health Was a Good Speculative Pick But Still Prefers UnitedHealth and CVS | ||
| IMUNON | 1,620 | 0,00 % | Imunon, Inc.: IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification | On track for enrollment of 80 participants by Q1 2027 Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer... ► Artikel lesen | |
| FULGENT GENETICS | 16,000 | +1,91 % | Fulgent reports interim data for cancer drug FID-007 trial | ||
| CAREDX | 22,000 | +0,92 % | CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last? | ||
| EMBECTA | 2,641 | -0,60 % | Embecta Corp.: embecta appoints Nimish Muzumdar as SVP and President, North America | PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| CHECK-CAP | 1,190 | -1,65 % | Humanoid Global gibt strategische Investition in MBody AI, Entwickler einer Autonomieplattform für verkörperte KI bekannt | - NICHT ZUR VERBREITUNG IN DEN VEREINIGTEN STAATEN ODER ÜBER US-NACHRICHTENDIENSTE BESTIMMT -
Vancouver, BC und Las Vegas, Nevada - 7. Januar 2026 / IRW-Press / Humanoid Global
... ► Artikel lesen | |
| ELECTROCORE | 7,000 | 0,00 % | electroCore, Inc.: electroCore Announces Full Year 2025 Financial Results and Organizational Changes | Record full year 2025 net sales of $32.0, an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general wellness... ► Artikel lesen | |
| CATHETER PRECISION | 0,942 | +12,10 % | Catheter Precision, Inc. - S-1, General form for registration of securities | ||
| CLEARPOINT NEURO | 18,540 | +8,68 % | ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains? | ||
| ENVUE MEDICAL | 0,639 | -8,77 % | ENvue Medical, Inc.: ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network | TYLER, Texas, June 05, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) ("ENvue," "ENvue Medical," or the "Company"), a commercial-stage medical device company focused on real-time guided bedside... ► Artikel lesen | |
| FIREFLY NEUROSCIENCE | 1,310 | -1,50 % | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | ||
| ENDRA LIFE SCIENCES | 5,160 | -0,39 % | Endra Raises $50 Million Series A To Build AI-Based Infrastructure Platform For MEP Engineering Firms | ||
| EXAGEN | 3,980 | +3,11 % | Exagen Inc. Reports First Quarter 2026 Results | CARLSBAD, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2026... ► Artikel lesen |
CUPRINA HOLDINGS CAYMAN LIMITED gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +0,51 % bei einem Aktienkurs von 3,950 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CUPRINA HOLDINGS CAYMAN LIMITED finden Sie auf Wallstreet Online.